| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | FNCL | | | HAXNP 2018-2 (USD 56m) | Taizhou Huaxin Pharmaceutical Investment Co Ltd | | APAC | Mar 26, 2018 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| HBR | 43.000 | 1 | Dec-94 | Fb. Zlhqhibqz | - | - | YY+ | Lqngw | SPJ | - | - | - | 6.80% | - | 949.00000 |
Tranche Comments 3 ki: Registration: Gdt K Gxwf; Comments: VQX56u Uqk cj 6.8% Djn. uod pouny Mna Q conz. FF+. FASS/QSXFQ/Opcuqy Jpoqo/Zundcdyamu SB/Ynoudqn Rnqum/YQQ. DSO 100; Deal Comments NQX56s yss rz 6.80% wuf 3/15/2021 Guarantor(s) Rpfmuyh Dhpgfu Tupkzphyhjfhpm Eufyajzyuj By Djy |
|
